Polymorphisms in Chlamydia trachomatis tryptophan synthase genes differentiate between genital and ocular isolates

Journal of Clinical Investigation

Volumn 111, Issue 11, 2003, Pages 1757-1769

  Caldwell, Harlan D ^a   Wood, Heidi ^b   Crane, Debbie ^a   Bailey, Robin ^c   Jones, Robert B ^d   Mabey, David ^c   Maclean, Ian ^e   Mohammed, Zeena ^b   Peeling, Rosanna ^b   Roshick, Christine ^e   Schachter, Julius ^f   Solomon, Anthony W ^c   Stamm, Walter E ^g   Suchland, Robert J ^g   Taylor, Lacey ^a   West, Sheila K ^h   Quinn, Tom C ⁱ   Belland, Robert J ^a   McClarty, Grant ^b,e  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MANITOBA   (Canada)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^h JOHNS HOPKINS UNIVERSITY   (United States)

ⁱ NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INDOLE; SYNTHETASE; TRYPTOPHAN; BACTERIAL ANTIGEN; INDOLE DERIVATIVE; MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN; TRYPTOPHAN SYNTHASE;

ARTICLE; BACTERIAL GENE; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM MUTANT; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INACTIVATION; ERADICATION THERAPY; EYE INFECTION; GENE MUTATION; GENETIC POLYMORPHISM; GENITAL TRACT INFECTION; GENOMICS; HELA CELL; HOST PARASITE INTERACTION; HUMAN; HUMAN CELL; NATURAL SELECTION; PATHOPHYSIOLOGY; PERSISTENT INFECTION; PRIORITY JOURNAL; SEROTYPE; STRAIN DIFFERENCE; TRACHOMA; TRPBA GENE; TRYPTOPHAN SYNTHASE GENE; VAGINA FLORA; CELL DIFFERENTIATION; ENZYMOLOGY; EYE; FEMALE; FEMALE GENITAL SYSTEM; GENETICS; METABOLISM; MICROBIOLOGY; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPECIES DIFFERENCE; WESTERN BLOTTING;

CHLAMYDIA TRACHOMATIS;

ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BASE SEQUENCE; BLOTTING, WESTERN; CELL DIFFERENTIATION; CHLAMYDIA TRACHOMATIS; EYE; FEMALE; GENITALIA, FEMALE; HELA CELLS; HUMANS; INDOLES; INTERFERON TYPE II; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPECIES SPECIFICITY; TRYPTOPHAN SYNTHASE;

EID: 0038481181     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI17993     Document Type: Article

References (63)

1. Moulder, J.W. 1991. Interaction of chlamydiae and host cells in vitro. Microbiol. Rev. 55:143-190.
2. Schachter, J. 1999. Infection and disease epidemiology. American Society for Microbiology Press. Washington, DC, USA. 139-170.
3. Stephens, R.S. 1999. Genomic autobiographies of Chlamydiae. American Society for Microbiology Press. Washington, DC, USA. 9-27.
4. An, B.B., and Adamis, A.P. 1998. Chlamydial ocular diseases. Int. Ophthalmol. Clin. 38:221-230.
5. Mabey, D., and Bailey, R. 1999. Eradication of trachoma worldwide. Br. J. Ophthalmol. 83:1261-1263.
6. Wang, S.P., and Grayston, J.T. 1970. Immunologic relationship between genital TRIC, lymphogranuloma venereum, and related organisms in a new microtiter indirect immunofluorescence test. Am. J. Ophthalmol. 70:367-374.
7. Stothard, D.R., Boguslawski, G., and Jones, R.B. 1998. Phylogenetic analysis of the Chlamydia trachomatis major outer membrane protein and examination of potential pathogenic determinants. Infect. Immun. 66:3618-3625.
8. Ikehata, M., Numazaki, K., and Chiba, S. 2000. Analysis of Chlamydia trachomatis serovars in endocervical specimens derived from pregnant Japanese women. FEMS Immunol. Med. Microbiol. 27:35-41.
9. Fraiz, J., and Jones, R.B. 1988. Chlamydial infections. Annu. Rev. Med. 39:357-370.
10. Schachter, J. 1989. Pathogenesis of chlamydial infections. Pathol. Immunopathol. Res. 8:206-220.
11. Smith, A., et al. 2001. OmpA genotypic evidence for persistent ocular Chlamydia trachomatis infection in Tanzanian village women. Ophthalmic Epidemiol. 8:127-135.
12. Brunham, R.C. 1999. Human immunity. American Society for Microbiology Press. Washington, DC, USA. 211-238.
13. Ward, M.E. 1999. Mechanisms of disease. American Society for Microbiology Press Washington, DC, USA. 171-210.
14. Ward, M.E. 1995. The immunobiology and immunopathology of chlamydial infections. APMIS. 103:769-796.
15. Read, T.D., et al. 2000. Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39. Nucleic Acids Res. 28:1397-1406.
16. Fehlner-Gardiner, C., et al. 2002. Molecular basis defining human Chlamydia trachomatis tissue tropism. A possible role for tryptophan synthase. J. Biol. Chem. 277:26893-26903.
17. Miles, E.W. 1995. Tryptophan synthase. Structure, function, and protein engineering. Subcell. Biochem. 24:207-254.
18. Miles, E.W. 2001. Tryptophan synthase: a multienzyme complex with an intramolecular tunnel. Chem. Rec. 1:140-151.
19. Miles, E.W. 1991. Structural basis for catalysis by tryptophan synthase. Adv. Enzymol. Relat. Areas Mol. Biol. 64:93-172.
20. Stephens, R.S., et al. 1998. Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science. 282:754-759.
21. Beatty, W.L., Morrison, R.P., and Byrne, G.I. 1994. Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis. Microbiol. Rev. 58:686-699.
22. Loomis, W.P., and Starnbach, M.N. 2002. T cell responses to Chlamydia trachomatis. Curr. Opin. Microbiol. 5:87-91.
23. Morrison, R.P., and Caldwell, H.D. 2002. Immunity to murine chlamydial genital infection. Infect. Immun. 70:2741-2751.
24. Kim, S.K., and DeMars, R. 2001. Epitope clusters in the major outer membrane protein of Chlamydia trachomatis. Curr. Opin. Immunol. 13:429-436.
25. Beatty, W.L., Belanger, T.A., Desai, A.A., Morrison, R.P., and Byrne, G.I. 1994. Tryptophan depletion as a mechanism of gamma interferon-mediated chlamydial persistence. Infect. Immun. 62:3705-3711.
26. Beatty, W.L., Morrison, R.P., and Byrne, G.I. 1995. Reactivation of persistent Chlamydia trachomatis infection in cell culture. Infect. Immun. 63:199-205.
27. Tipples, G., and McClarty, G. 1991. Isolation and initial characterization of a series of Chlamydia trachomatis isolates selected for hydroxyurea resistance by a stepwise procedure. J. Bacteriol. 173:4932-4940.
28. Hsieh, Y.H., Bobo, L.D., Quinn, T.C., and West, S.K. 2001. Determinants of trachoma endemicity using Chlamydia trachomatis ompA DNA sequencing. Microbes Infect. 3:447-458.
29. Conway, D.J., et al. 1997. Scarring trachoma is associated with polymorphism in the tumor necrosis factor alpha (TNF-alpha) gene promoter and with elevated TNF-alpha levels in tear fluid. Infect. Immun. 65:1003-1006.
30. Brunham, R.C., et al. 1996. The epidemiology of Chlamydia trachomatis within a sexually transmitted diseases core group. J. Infect. Dis. 173:950-956.
31. Geisler, W.M., Whittington, W.L., Suchland, R.J., and Stamm, W.E. 2002. Epidemiology of anorectal chlamydial and gonococcal infections among men having sex with men in Seattle: utilizing serovar and auxotype strain typing. Sex. Transm. Dis. 29:189-195.
32. Van Der Pol, B., et al. 2001. Multicenter evaluation of the BDProbeTec ET System for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine specimens, female endocervical swabs, and male urethral swabs. J. Clin. Microbiol. 39:1008-1016.
33. Caldwell, H.D., Kromhout, J., and Schachter, J. 1981. Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect. Immun. 31:1161-1176.
34. Morrison, R.P. 2000. Differential sensitivities of Chlamydia trachomatis strains to inhibitory effects of gamma interferon. Infect. Immun. 68:6038-6040.
35. Shaw, A.C., Christiansen, G., Roepstorff, P., and Birkelund, S. 2000. Genetic differences in the Chlamydia trachomatis tryptophan synthase alpha-subunit can explain variations in serovar pathogenesis. Microbes Infect. 2:581-592.
36. Frost, E.H, Deslandes, S., Gendron, D., Bourgaux-Ramoisy, D., and Bourgaux, P. 1995. Variation outside variable segments of the major outer membrane protein distinguishes trachoma from urogenital isolates of the same serovar of Chlamydia trachomatis. Genitourin. Med. 71:18-23.
37. Perry, L.L., Feilzer, K., and Caldwell, H.D. 1997. Immunity to Chlamydia trachomatis is mediated by T helper 1 cells through IFN-gamma-dependent and -independent pathways. J. Immunol. 158:3344-3352.
38. Taylor, M.W., and Feng, G.S. 1991. Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J. 5:2516-2522.
39. Boehm, U., Klamp, T., Groot, M., and Howard, J.C. 1997. Cellular responses to interferon-gamma. Annu. Rev. Immunol. 15:749-795.
40. Crawford, I.P. 1989. Evolution of a biosynthetic pathway: the tryptophan paradigm. Annu. Rev. Microbiol. 43:567-600.
41. Crawford, I.P., and Stauffer, G.V. 1980. Regulation of tryptophan biosynthesis. Annu. Rev. Biochem. 49:163-195.
42. Kalman, S., et al. 1999. Comparative genomes of Chlamydia pneumoniae and C. trachomatis. Nat. Genet. 21:385-389.
43. Pfefferkorn, E.R. 1984. Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proc. Natl. Acad. Sci. U. S. A. 81:908-912.
44. Dai, W., Pan, H., Kwok, O., and Dubey, J.P. 1994. Human indoleamine 2,3-dioxygenase inhibits Toxoplasma gondii growth in fibroblast cells. J. Interferon Res. 14:313-317.
45. Beatty, W.L., Morrison, R.P., and Byrne, G.I. 1994. Immunoelectron-microscopic quantitation of differential levels of chlamydial proteins in a cell culture model of persistent Chlamydia trachomatis infection. Infect. Immun. 62:4059-4062.
46. Gibbs, R.S. 1987. Microbiology of the female genital tract. Am. J. Obstet. Gynecol. 156:491-495.
47. Larsen, B., and Monif, G.R. 2001. Understanding the bacterial flora of the female genital tract. Clin. Infect. Dis. 32:e69-e77.
48. Balows, A. 1991. The prokaryotes. Springer-Verlag. New York, New York, USA. 1886-1887.
49. Morris, M., Nicoll, A., Simms, I., Wilson, J., and Catchpole, M. 2001. Bacterial vaginosis: a public health review. BJOG. 108:439-450.
50. Hillier, S.L. 1993. Diagnostic microbiology of bacterial vaginosis. Am. J. Obstet. Gynecol. 169:455-459.
51. Hill, G.B. 1993. The microbiology of bacterial vaginosis. Am. J. Obstet. Gynecol. 169:450-454.
52. Hellberg, D., Nilsson, S., and Mardh, P.A. 2001. The diagnosis of bacterial vaginosis and vaginal flora changes. Arch. Gynecol. Obstet. 265:11-15.
53. Jossens, M.O., Schachter, J., and Sweet, R.L. 1994. Risk factors associated with pelvic inflammatory disease of differing microbial etiologies. Obstet. Gynecol. 83:989-997.
54. Paavonen, J., et al. 1987. Microbiological and histopathological findings in acute pelvic inflammatory disease. Br. J. Obstet. Gynaecol. 94:454-460.
55. Wiesenfeld, H.C., et al. 2002. Lower genital tract infection and endometritis: insight into subclinical pelvic inflammatory disease. Obstet. Gynecol. 100:456-463.
56. Weyand, M., and Schlichting, I. 1999. Crystal structure of wild-type tryptophan synthase complexed with the natural substrate indole-3-glycerol phosphate. Biochemistry. 38:16469-16480.
57. Chern, K.C., et al. 1999. Alterations in the conjunctival bacterial flora following a single dose of azithromycin in a trachoma endemic area. Br. J. Ophthalmol. 83:1332-1335.
58. Peterson, J., and Treadway, G. 1998. Impact of community-based azithromycin treatment of trachoma on carriage and resistance of Streptococcus pneumoniae. Clin. Infect. Dis. 26:248-249.
59. Alrawi, A.M., et al. 2002. Biotypes and serotypes of Haemophilus influenzae ocular isolates. Br. J. Ophthalmol. 86:276-277.
60. Bobo, L., et al. 1996. Evidence for a predominant proinflammatory conjunctival cytokine response in individuals with trachoma. Infect. Immun. 64:3273-3279.
61. Holland, M.J., et al. 1996. T helper type-1 (Th1)/Th2 profiles of peripheral blood mononuclear cells (PBMC); responses to antigens of Chlamydia trachomatis in subjects with severe trachomatous scarring. Clin. Exp. Immunol. 105:429-435.
62. Geiger, K., and Sarvetnick, N. 1994. Local production of IFN-gamma abrogates the intraocular immune privilege in transgenic mice and prevents the induction of ACAID. J. Immunol. 153:5239-5246.
63. Geiger, K.D., and Sarvetnick, N.E. 1996. Ocular production of interferon-gamma and lack of major histocompatibility complex molecules induce immunological changes in the intraocular environment. Ger. J. Ophthalmol. 5:309-314.